skip to main |
skip to sidebar
Data shows vaccine effective for late stage melanoma
REUTERS – Mar. 14, 2014 – Updating data from an ongoing
clinical trial of 295 patients with advanced melanoma show the vaccine drug
effective in shrinking both tumors directly injected with the vaccine and un-injected
tumors. The result indicates the vaccine had the desired effect of triggering
the immune system to attack cancer cells elsewhere in the body. Sixty-four
percent of the directly injected tumors shrank by half, and 47 percent of the
tumors disappeared. Of the un-injected tumors, 34 percent shrank by at least half, and 21 percent of those disappeared. The findings were presented at the Society of
Surgical Oncology Cancer Symposium in Phoenix.
No comments:
Post a Comment